Avidity Partners Management LP Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$2.9T
Holdings
93
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (93 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BDXBECTON DICKINSON & CO | 398,050 | $105.1B | 3.67% | |
| 2 | KRTXKARUNA THERAPEUTICS INC | 442,200 | $95.9B | 3.35% | |
| 3 | JAZZJAZZ PHARMACEUTICALS PLC | 702,778 | $87.1B | 3.04% | |
| 4 | GEHCGE HEALTHCARE TECHNOLOGIES I | 1,045,400 | $84.9B | 2.97% | |
| 5 | THCTENET HEALTHCARE CORP | 990,500 | $80.6B | 2.82% | |
| 6 | ARGXARGENX SE | 184,300 | $71.8B | 2.51% | |
| 7 | IDYAIDEAYA BIOSCIENCES INC | 2,985,700 | $70.2B | 2.45% | |
| 8 | SGRYSURGERY PARTNERS INC | 1,555,000 | $70.0B | 2.44% | |
| 9 | ABBVABBVIE INC | 518,400 | $69.8B | 2.44% | |
| 10 | ARVNARVINAS INC | 2,773,189 | $68.8B | 2.40% | |
| 11 | ZNTLZENTALIS PHARMACEUTICALS INC | 2,334,000 | $65.8B | 2.30% | |
| 12 | NBIXNEUROCRINE BIOSCIENCES INC | 665,316 | $62.7B | 2.19% | |
| 13 | LLYLILLY ELI & CO | 133,000 | $62.4B | 2.18% | |
| 14 | SNDXSYNDAX PHARMACEUTICALS INC | 2,872,000 | $60.1B | 2.10% | |
| 15 | UHSUNIVERSAL HLTH SVCS INC | 370,100 | $58.4B | 2.04% | |
| 16 | BUWABIO RAD LABS INC | 152,600 | $57.9B | 2.02% | |
| 17 | ABGAMERISOURCEBERGEN CORP | 300,000 | $57.7B | 2.02% | |
| 18 | PACBPACIFIC BIOSCIENCES CALIF IN | 4,337,400 | $57.7B | 2.01% | |
| 19 | LEGNLEGEND BIOTECH CORP | 798,900 | $55.1B | 1.93% | |
| 20 | BIIBBIOGEN INC | 174,000 | $49.6B | 1.73% | |
| 21 | AKROAKERO THERAPEUTICS INC | 1,025,000 | $47.9B | 1.67% | |
| 22 | CVACCUREVAC N V | 4,300,000 | $44.8B | 1.56% | |
| 23 | ACHCACADIA HEALTHCARE COMPANY IN | 550,000 | $43.8B | 1.53% | |
| 24 | PCVXVAXCYTE INC | 875,000 | $43.7B | 1.53% | |
| 25 | MCKMCKESSON CORP | 101,200 | $43.2B | 1.51% | |
| 26 | APLSAPELLIS PHARMACEUTICALS INC | 468,700 | $42.7B | 1.49% | |
| 27 | BSXBOSTON SCIENTIFIC CORP | 785,700 | $42.5B | 1.48% | |
| 28 | RAREULTRAGENYX PHARMACEUTICAL IN | 900,700 | $41.5B | 1.45% | |
| 29 | PFEPFIZER INC | 1,117,467 | $41.0B | 1.43% | |
| 30 | IMVTIMMUNOVANT INC | 2,085,000 | $39.6B | 1.38% | |
| 31 | AXSMAXSOME THERAPEUTICS INC | 545,000 | $39.2B | 1.37% | |
| 32 | IMGNEURIMMUNOGEN INC | 1,997,800 | $37.7B | 1.32% | |
| 33 | ZTSZOETIS INC | 217,000 | $37.4B | 1.31% | |
| 34 | PRTAPROTHENA CORP PLC | 535,000 | $36.5B | 1.28% | |
| 35 | VIRVIR BIOTECHNOLOGY INC | 1,425,000 | $35.0B | 1.22% | |
| 36 | IMCRIMMUNOCORE HLDGS PLC | 575,000 | $34.5B | 1.20% | |
| 37 | SRPTSAREPTA THERAPEUTICS INC | 297,500 | $34.1B | 1.19% | |
| 38 | ARWRARROWHEAD PHARMACEUTICALS IN | 925,000 | $33.0B | 1.15% | |
| 39 | BHVNBIOHAVEN LTD | 1,325,000 | $31.7B | 1.11% | |
| 40 | RVMDREVOLUTION MEDICINES INC | 1,075,000 | $28.8B | 1.00% | |
| 41 | PRVAPRIVIA HEALTH GROUP INC | 1,079,806 | $28.2B | 0.98% | |
| 42 | PHATPHATHOM PHARMACEUTICALS INC | 1,949,700 | $27.9B | 0.98% | |
| 43 | BAXBAXTER INTL INC | 604,700 | $27.6B | 0.96% | |
| 44 | —FUSION PHARMACEUTICALS INC | 5,700,000 | $26.6B | 0.93% | |
| 45 | RCKTROCKET PHARMACEUTICALS INC | 1,326,000 | $26.3B | 0.92% | |
| 46 | 2L9BLUEPRINT MEDICINES CORP | 415,000 | $26.2B | 0.92% | |
| 47 | EDITEDITAS MEDICINE INC | 3,000,000 | $24.7B | 0.86% | |
| 48 | VTYXVENTYX BIOSCIENCES INC | 692,500 | $22.7B | 0.79% | |
| 49 | NTRANATERA INC | 432,900 | $21.1B | 0.74% | |
| 50 | LNTHLANTHEUS HLDGS INC | 245,100 | $20.6B | 0.72% | |
| 51 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 400,000 | $20.4B | 0.71% | |
| 52 | VRNAVERONA PHARMA PLC | 954,500 | $20.2B | 0.70% | |
| 53 | AMLXAMYLYX PHARMACEUTICALS INC | 901,400 | $19.4B | 0.68% | |
| 54 | AXNX*AXONICS INC | 379,700 | $19.2B | 0.67% | |
| 55 | XENEXENON PHARMACEUTICALS INC | 481,300 | $18.5B | 0.65% | |
| 56 | REGNREGENERON PHARMACEUTICALS | 24,800 | $17.8B | 0.62% | |
| 57 | ROIVROIVANT SCIENCES LTD | 1,687,500 | $17.0B | 0.59% | |
| 58 | PLRXPLIANT THERAPEUTICS INC | 916,600 | $16.6B | 0.58% | |
| 59 | VERVVERVE THERAPEUTICS INC | 878,600 | $16.5B | 0.58% | |
| 60 | NTLAINTELLIA THERAPEUTICS INC | 395,855 | $16.1B | 0.56% | |
| 61 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 501,200 | $15.9B | 0.56% | |
| 62 | SLRNACELYRIN INC | 750,000 | $15.7B | 0.55% | |
| 63 | —POINT BIOPHARMA GLOBAL INC | 1,671,800 | $15.1B | 0.53% | |
| 64 | KPTIEURKARYOPHARM THERAPEUTICS INC | 8,370,100 | $15.0B | 0.52% | |
| 65 | KZRKEZAR LIFE SCIENCES INC | 6,080,000 | $14.9B | 0.52% | |
| 66 | SDGRSCHRODINGER INC | 274,900 | $13.7B | 0.48% | |
| 67 | TSVT*2SEVENTY BIO INC | 1,342,000 | $13.6B | 0.47% | |
| 68 | MLYSMINERALYS THERAPEUTICS INC | 766,700 | $13.1B | 0.46% | |
| 69 | —MERSANA THERAPEUTICS INC | 3,790,000 | $12.5B | 0.44% | |
| 70 | CRBUCARIBOU BIOSCIENCES INC | 2,758,600 | $11.7B | 0.41% | |
| 71 | NSTGEURNANOSTRING TECHNOLOGIES INC | 2,700,400 | $10.9B | 0.38% | |
| 72 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,058,500 | $10.9B | 0.38% | |
| 73 | NARIUSDINARI MED INC | 175,000 | $10.2B | 0.36% | |
| 74 | ETNBGBP89BIO INC | 526,376 | $10.0B | 0.35% | |
| 75 | ACIUAC IMMUNE SA | 2,903,278 | $8.6B | 0.30% | |
| 76 | DNLIDENALI THERAPEUTICS INC | 282,752 | $8.3B | 0.29% | |
| 77 | COLLCOLLEGIUM PHARMACEUTICAL INC | 354,100 | $7.6B | 0.27% | |
| 78 | ATECALPHATEC HLDGS INC | 393,000 | $7.1B | 0.25% | |
| 79 | ANTXAN2 THERAPEUTICS INC | 657,200 | $5.6B | 0.20% | |
| 80 | 2JQGRITSTONE BIO INC | 2,765,500 | $5.4B | 0.19% | |
| 81 | CMPXCOMPASS THERAPEUTICS INC | 1,620,200 | $5.2B | 0.18% | |
| 82 | SCYXSCYNEXIS INC | 1,738,734 | $5.1B | 0.18% | |
| 83 | SYRSSYROS PHARMACEUTICALS INC | 1,464,034 | $4.6B | 0.16% | |
| 84 | ALTALTIMMUNE INC | 1,174,100 | $4.1B | 0.14% | |
| 85 | IPSCCENTURY THERAPEUTICS INC | 1,110,900 | $3.5B | 0.12% | |
| 86 | HYPRHYPERFINE INC | 1,188,178 | $2.6B | 0.09% | |
| 87 | SLPSIMULATIONS PLUS INC | 45,900 | $2.0B | 0.07% | |
| 88 | —CAREMAX INC | 636,000 | $2.0B | 0.07% | |
| 89 | BHCBAUSCH HEALTH COS INC | 215,100 | $1.7B | 0.06% | |
| 90 | GPCRSTRUCTURE THERAPEUTICS INC | 37,800 | $1.6B | 0.05% | |
| 91 | EXAIEUREXSCIENTIA PLC | 127,600 | $755.4M | 0.03% | |
| 92 | AIPARTERIS INC | 75,500 | $514.9M | 0.02% | |
| 93 | NUVB/WSNUVATION BIO INC | 90,560 | $15.0M | 0.00% |